glp-1 or metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes | Diabetologia Semaglutide dominates GLP-1 receptor agonist
Description
Monitor for unusual symptoms Pay attention to any changes in the 24-48 hours after injection
For those who cannot continue GLP-1 therapy, other FDA-approved anti-obesity medications may be considered
H., & Dailey, M
Fan YC, Peng SY, Chang CK, et al
Gradual increases over several weeks are recommended
At this stage, no GLP1 drug is FDAapproved specifically for reducing alcohol use
